Skip to main content
Article thumbnail
Location of Repository

Increased intracellular Ca2+ selectively suppresses IL-1-induced NO production by reducing iNOS mRNA stability



This study addresses the role of intracellular calcium (Ca2+) in the expression of iNOS, an IL-1 inducible gene in human articular chondrocytes. The calcium ionophore A23187 and ionomycin did not induce NO release or iNOS expression but inhibited dose dependently IL-1- induced NO release with IC50 of 200 nM and 100 nM, respectively. Increased intracellular Ca2+ induced by thapsigargin or cyclopiazonic acid, inhibitors of the endoplasmic reticulum Ca2+ ATPase, had similar inhibitory effects with IC50 of 1 nM and 3 microM, respectively. LPS and TNF alpha induced NO production were also suppressed by these Ca2+ elevating drugs. Levels of IL-1-induced iNOS protein were reduced by A23187, thapsigargin, and cyclopiazonic acid. These drugs as well as Bay K 8644 and KCl inhibited IL-1-induced iNOS mRNA expression. To analyze the role of Ca2+ in the expression of other IL-1 responsive genes in chondrocytes, these Ca2+ modulating drugs were tested for effects on COXII. In contrast to the inhibitory effects on iNOS mRNA, these drugs induced COXII mRNA expression and in combination with IL-1, enhanced COXII mRNA levels. Ca2+ mediated increases in COXII mRNA expression were associated with an increase in COXII protein. The kinetics of Ca2+ effects on IL-1-induced iNOS mRNA levels suggested a posttranscriptional mechanism. Analysis of iNOS mRNA half life showed that it was 6-7 h in IL-1-stimulated cells and decreased by A23187 to 2- 3 h. In conclusion, these results show that Ca2+ inhibits IL-1-induced NO release, iNOS protein, and mRNA expression in human articular chondrocytes by reducing iNOS mRNA stability. Under identical conditions increased Ca2+ enhances IL-1-induced COXII gene and protein expression

Topics: Articles
Publisher: The Rockefeller University Press
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. A 1-hour pulse with IL-1 beta induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: evidence for a tyrosine kinase signaling mechanism.
    2. (1986). A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.
    3. a tumor promoter, discharges intracellular Ca 2+ stores by specific inhibition of the endoplasmic reticulum
    4. (1991). Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide.
    5. (1989). C~clopiazonic acid is a specific inhibitor of the Ca2+-ATPase of sarcoplasmic reticulum.
    6. Ca2+/calmodulin-regulated nitric oxide synthases.
    7. (1994). Calcium signaling in endothelin- and platelet-derived growth factor-stimulated chondrocytes.
    8. (1992). Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme.
    9. (1991). Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase.
    10. (1992). Cloning and characterization of inducible nitric oxide synthase from mouse macrophages.
    11. (1992). Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase.
    12. (1993). Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte.
    13. (1993). Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. Synergism with the induction elicited by inflammatory cytokines.
    14. (1992). Epidermal growth factor suppresses nitric oxide and hydrogen peroxide produc tion by keratinocytes. Potential role for nitric oxide in the regulation of wound healing.
    15. (1994). Growth factor responsiveness of human articular chondrocytes: distinct profiles in primary chondrocytes, subcultured chondrocytes, and fibroblasts.
    16. (1994). HIV-1 transactivator protein Tat induces proliferation and TGF !~ expression in human articular chondrocytes.
    17. (1986). Identification of a common nueleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.
    18. (1995). IL-1 induced nitric oxide inhibits chrondrocyte proliferation via PGE2. Exp. Cell Res. In
    19. (1994). Inducible nitric oxide synthase from human articular chondrocytes: cDNA cloning and analysis of mRNA expression.
    20. (1994). Inducible nitric-oxide-synthase mRNA is transiently expressed and destroyed by a cycloheximidesensitive process.
    21. (1990). Induction of nitric oxide Synthase by cytokines in vascular smooth muscle ceils.
    22. Induction of nitric oxide synthase in human chondrocytes.
    23. (1994). Mechanisms of cytokine-induced destruction of rat insulinoma cells: the role of nitric oxide.
    24. (1993). Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta.
    25. (1993). Messenger RNA degradation in eukaryotes.
    26. (1992). Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase.
    27. (1993). Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes.
    28. (1993). Nitric oxide and arthritis. Arthritis Rheum.
    29. (1993). Nitric oxide production by mufine macrophages is inhibited by prolonged elevation of cyclic AMP.
    30. (1992). Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites.
    31. (1994). Nitric oxide synthases: roles, tolls, and controls.
    32. (1992). Nitric oxide, a novel biologic messenger.
    33. (1992). Phorbol esters induce hiThe
    34. (1993). Phorbol esters induce nitric oxide synthase and increase arginine influx in cultured peritoneal macrophages.
    35. (1991). Phosphorylation by calcium calmodulin-dependent protein kinase If and protein kinase C modulates the activity of nitric oxide synthase.
    36. (1991). Phosphorylation of nitric oxide synthase by protein kinase
    37. (1991). Protein phosphorylation and metalloproteinase synthesis by lapine articular chondrocytes.
    38. (1993). Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in lipopolysaccharide-responsive and lipopolysaccharide-nonresponsive murine macrophages.
    39. (1995). Regulation of cyclooxygenase II expression in human articular chondrocytes.
    40. (1995). Signaling pathways involved with the expression of inducible nitric oxide syntase in human articular chondrocytes. J. Cell Physiol.
    41. (1994). The inducible production of nitric oxide by articular cell types. Osteoarthritis and Cartilage.
    42. (1992). The role of protein kinase C in the induction of nitric oxide synthesis by murine maerophages.
    43. (1991). Transforming growth factor beta 2 inhibits interleukin 1 beta- and tumour necrosis factor alpha-induction of nitric oxide synthase in rat renal mesangial cells.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.